Research Grade Albiglutide|Albiglutide（研究用级别）(靶标：阿必鲁肽)
- 货号：RB9THW328306
- 价格：面议
- 点击：219
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Human |
| 抗体亚型 | Fusion - (GCG (glucagon) 98-127 (glucagon-like pep |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Purified by ion exchange chromatography. |
| 浓度 | 0.5mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | GLP-1 receptor, Glucagon-like peptide 1 receptor, GLP1R, GLP-1-R, GLP-1R |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | P43220 |
| 背景信息 | Liraglutide, 97% similar to native human GLP-1, differs primarily by substituting arginine for lysine at position 34 and involves attaching a C-16 fatty acid (palmitic acid) with a glutamic acid spacer at the remaining lysine residue at position 26. • The physiology of glucagon-like peptide 1., PMID:17928588 • Glucagon-like peptide-1 receptor: mechanisms and advances in therapy., PMID:39289339 • The structure and function of the glucagon-like peptide-1 receptor and its ligands., PMID:21950636 • Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist., PMID:33177239 • Glucagon-like peptide-1 receptor., PMID:39626623 • Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types., PMID:39777709 • Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials., PMID:28244632 • Glucagon-like-peptide 1 receptor agonism and attempted suicide: A Mendelian randomisation study to assess a potential causal association., PMID:38778795 • Glucagon-Like Peptide-1 Receptor Agonism and Suicide Risk: Evidence From Mendelian Randomization., PMID:38879463 • GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis., PMID:39735270 |
| 别名 | GSK716155, SyncriaEPERZAN®(EU), TANZEUM®(US) |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 炔诺酮单抗 | 5641 |
| 磺胺氯吡嗪单抗 | 5655 |
| 呋喃苯烯酸钠单抗 | 5527 |
| 呋喃它酮代谢物（2-NPAMOZ）单抗 | 5494 |
| 呋喃西林代谢物（2-NPSEM）单抗 | 5357 |
| 磺胺喹恶啉单抗 | 5562 |
| 苯丙酸诺龙单抗 | 5476 |
| 司帕沙星单抗 | 5312 |
| 妥布霉素单抗 | 5543 |
| 甲氧氯普胺单抗 | 5426 |
| 莫能菌素单抗 | 5519 |
| 多粘菌素B（粘菌素）单抗 | 5841 |
| 磺胺类单抗 | 5668 |
| 托灭酸（托芬那酸）单抗 | 5437 |
| 卡洛芬单抗 | 5371 |
| 喹乙醇代谢物MQCA单抗 | 5534 |
| 氟尼辛单抗 | 5446 |
| 磺胺二甲嘧啶（SM2）单抗 | 5286 |
| 诺龙（19-去甲睾酮）单抗 | 5379 |
| 阿苯达唑-2-氨基砜单抗 | 5341 |